FDA-approved buprenorphine formulations for MOUD and analgesia50
| Milligram formulations of MOUD | |
| Buprenorphine+naloxone | Buprenorphine |
| Sublingual tablets (Zubsolv) | Sublingual tablets |
| Sublingual film (Suboxone) | ER solution for injection (Sublocade, Brixadi*) |
| Buccal film (Bunavail) | |
| Microgram formulations for analgesia† | |
| Transdermal patch (Butrans) weekly application | |
| Buccal film (Belbuca) | |
*Tentative approval from FDA (not eligible for marketing in the USA. Date to be determined (TBD).
†Low abuse potential.146 147
ER, extended release; FDA, Food and Drug Administration; MOUD, medication treatment of opioid use disorder.